These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Time to revisit the Health Insurance Portability and Accountability Act (HIPAA)? Accelerated telehealth adoption during the COVID-19 pandemic. Bhate C; Ho CH; Brodell RT J Am Acad Dermatol; 2020 Oct; 83(4):e313-e314. PubMed ID: 32603725 [No Abstract] [Full Text] [Related]
3. Teledermatology in the wake of COVID-19: Advantages and challenges to continued care in a time of disarray. Gupta R; Ibraheim MK; Doan HQ J Am Acad Dermatol; 2020 Jul; 83(1):168-169. PubMed ID: 32334056 [No Abstract] [Full Text] [Related]
4. Implications for Telehealth in a Postpandemic Future: Regulatory and Privacy Issues. Shachar C; Engel J; Elwyn G JAMA; 2020 Jun; 323(23):2375-2376. PubMed ID: 32421170 [No Abstract] [Full Text] [Related]
8. President's message: the impact of the COVID-19 public health emergency on the practice of addiction medicine. Kmiec J J Addict Dis; 2020; 38(2):235-236. PubMed ID: 32397851 [No Abstract] [Full Text] [Related]
9. Covid-19 and Health Care's Digital Revolution. Keesara S; Jonas A; Schulman K N Engl J Med; 2020 Jun; 382(23):e82. PubMed ID: 32240581 [No Abstract] [Full Text] [Related]
10. Outpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned. Farshchian M; Potts G; Kimyai-Asadi A; Mehregan D; Daveluy S J Drugs Dermatol; 2020 Jun; 19(6):683. PubMed ID: 32574014 [No Abstract] [Full Text] [Related]
11. Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer. Spiess PE; Greene J; Keenan RJ; Paculdo D; Letson GD; Peabody JW Cancer; 2020 Jul; 126(14):3174-3175. PubMed ID: 32324273 [TBL] [Abstract][Full Text] [Related]
12. Telemedicine continues to wrestle wicked problems: reimbursement, licensure, and bandwidth rules (or is it compliance?). Sandberg LA Health Manag Technol; 1999 Feb; 20(1):134, 133. PubMed ID: 10345929 [No Abstract] [Full Text] [Related]
13. Analysis of availability, types, and implementation of teledermatology services during COVID-19. Gorrepati PL; Smith GP J Am Acad Dermatol; 2020 Sep; 83(3):958-959. PubMed ID: 32531304 [No Abstract] [Full Text] [Related]
14. Health Care Policy and Regulatory Challenges for Adoption of Telemedicine in Kidney Transplantation. Al Ammary F; Sidoti C; Segev DL; Henderson ML Am J Kidney Dis; 2021 May; 77(5):773-776. PubMed ID: 33171215 [No Abstract] [Full Text] [Related]
15. Logistics of Rehabilitation Telehealth: Documentation, Reimbursement, and Health Insurance Portability and Accountability Act. Chan AH Phys Med Rehabil Clin N Am; 2021 May; 32(2):429-436. PubMed ID: 33814067 [TBL] [Abstract][Full Text] [Related]
16. The Tele-Future is Now: Will Telemedicine's Footprint Be Permanent Post-COVID-19? Berlin J Tex Med; 2020 Jul; 116(7):14-19. PubMed ID: 32872705 [No Abstract] [Full Text] [Related]
17. Personal Experiences With Coronavirus Disease 2019 and Diabetes: The Time for Telemedicine is Now. Mader JK J Diabetes Sci Technol; 2020 Jul; 14(4):752-753. PubMed ID: 32443942 [No Abstract] [Full Text] [Related]
18. Privacy in the Coronavirus Era. Labs J; Terry S Genet Test Mol Biomarkers; 2020 Sep; 24(9):535-536. PubMed ID: 32677850 [No Abstract] [Full Text] [Related]
19. Telehealth Success Spurs a Call for Greater Post-COVID-19 License Portability. Slomski A JAMA; 2020 Sep; 324(11):1021-1022. PubMed ID: 32930757 [No Abstract] [Full Text] [Related]
20. Rapid implementation of virtual neurology in response to the COVID-19 pandemic. Grossman SN; Han SC; Balcer LJ; Kurzweil A; Weinberg H; Galetta SL; Busis NA Neurology; 2020 Jun; 94(24):1077-1087. PubMed ID: 32358217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]